Operating

Accretion (amortization) of discounts and premiums on investments

Roivant Sciences Accretion (amortization) of discounts and premiums on investments decreased by 11.2% to $8.72M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 70.2%, from $29.27M to $8.72M.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ3 2025Feb 6, 2026

How to read this metric

Reflects the yield characteristics of the investment portfolio; changes are driven by interest rate environments and bond pricing.

Detailed definition

This reflects the non-cash adjustment for the difference between the purchase price and the par value of fixed-income se...

Peer comparison

Common in insurance and banking sectors where large investment portfolios are held.

Metric ID: bac_accretion_amortization_investments

Historical Data

13 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$25.04M$29.27M$15.66M$11.06M$9.82M$8.72M
QoQ Change+16.9%-46.5%-29.3%-11.2%-11.2%
YoY Change-60.8%-70.2%
Range$0.00$29.27M
Avg YoY Growth-65.5%
Median YoY Growth-65.5%
Current Streak4 quarters decline

Accretion (amortization) of discounts and premiums on investments at Other Companies

Frequently Asked Questions

What is Roivant Sciences's accretion (amortization) of discounts and premiums on investments?
Roivant Sciences (ROIV) reported accretion (amortization) of discounts and premiums on investments of $8.72M in Q4 2025.
How has Roivant Sciences's accretion (amortization) of discounts and premiums on investments changed year-over-year?
Roivant Sciences's accretion (amortization) of discounts and premiums on investments decreased by 70.2% year-over-year, from $29.27M to $8.72M.
What does accretion (amortization) of discounts and premiums on investments mean?
Non-cash adjustments to the value of investment securities held by the company.